Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

被引：386

作者：

Sniderman, AD

Furberg, CD

Keech, A

van Lennep, JER

Frohlich, J

Jungner, I

Walldius, G

机构：

[1] McGill Univ, McGill Univ Hlth Ctr, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ, Canada

[2] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA

[3] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada

[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[7] St Gorans Univ Hosp, CALAB Res, Stockholm, Sweden

[8] Karolinska Inst, Karolinska Hosp, Clin Epidemiol Unit, S-10401 Stockholm, Sweden

[9] AstraZeneca, Molndal, Sweden

[10] Karolinska Inst, King Gustaf V Res Inst, Stockholm, Sweden

来源：

LANCET | 2003年 / 361卷 / 9359期

关键词：

D O I：

10.1016/S0140-6736(03)12663-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：777 / 780

页数：4

共 17 条

[1] Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme a reductase inhibitors on non-high-density lipoprotein cholesterol levels [J].

Ballantyne, CM ;

Andrews, TC ;

Hsia, JA ;

Kramer, JH ;

Shear, C .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :265-269

[2] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[3]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[4]

Durrington PN, 2002, CLIN CHEM, V48, P401

[5] Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) [J].

Gotto, AM ;

Whitney, E ;

Stein, EA ;

Shapiro, DR ;

Clearfield, M ;

Weis, S ;

Jou, JY ;

Langendörfer, A ;

Beere, A ;

Watson, DJ ;

Downs, JR ;

de Cani, JS .

CIRCULATION, 2000, 101 (05) :477-484

[6] Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study [J].

Lamarche, B ;

Moorjani, S ;

Lupien, PJ ;

Cantin, B ;

Bernard, PM ;

Dagenais, GR ;

Despres, JP .

CIRCULATION, 1996, 94 (03) :273-278

[7]

Miremadi S, 2002, CLIN CHEM, V48, P484

[8] Thrombogenic factors and recurrent coronary events [J].

Moss, AJ ;

Goldstein, RE ;

Marder, VJ ;

Sparks, CE ;

Oakes, D ;

Greenberg, H ;

Weiss, HJ ;

Zareba, W ;

Brown, MW ;

Liang, CS ;

Lichstein, E ;

Little, WC ;

Gillespie, JA ;

Van Voorhees, L ;

Krone, RJ ;

Bodenheimer, MM ;

Hochman, J ;

Dwyer, EM ;

Arora, R ;

Marcus, FI ;

Watelet, LFM ;

Case, RB .

CIRCULATION, 1999, 99 (19) :2517-2522

[9]

Otvos JD, 2002, AM J CARDIOL, V90, p22I

[10] Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study [J].

Pedersen, TR ;

Olsson, AG ;

Færgeman, O ;

Kjekshus, J ;

Wedel, H ;

Berg, K ;

Wilhelmsen, L ;

Haghfelt, T ;

Thorgeirsson, G ;

Pyörälä, K ;

Miettinen, T ;

Christophersen, B ;

Tobert, JA ;

Musliner, TA ;

Cook, TJ .

CIRCULATION, 1998, 97 (15) :1453-1460

← 1 2 →